Last reviewed · How we verify

aspirin,chinese herbs;

Guangzhou University of Traditional Chinese Medicine · FDA-approved active Small molecule

A combination of aspirin and Chinese herbal ingredients that work together to reduce inflammation, inhibit platelet aggregation, and promote blood circulation.

A combination of aspirin and Chinese herbal ingredients that work together to reduce inflammation, inhibit platelet aggregation, and promote blood circulation. Used for Cardiovascular disease prevention and treatment, Thrombotic disorders.

At a glance

Generic nameaspirin,chinese herbs;
Also known asBayer
SponsorGuangzhou University of Traditional Chinese Medicine
Drug classAntiplatelet agent with herbal adjunct
TargetCOX-1 (aspirin component); herbal targets not well-defined
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, reducing thromboxane A2 production and platelet aggregation while providing anti-inflammatory effects. The Chinese herbal components are intended to enhance circulation, reduce blood viscosity, and provide additional anti-inflammatory and antithrombotic benefits through traditional mechanisms not fully characterized by Western pharmacology.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: